Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Non-Current Deffered Revenue: 2010

Historic Non-Current Deffered Revenue for Madrigal Pharmaceuticals (MDGL) over the last 1 years, with Dec 2010 value amounting to $2.2 million.

  • Madrigal Pharmaceuticals' Non-Current Deffered Revenue was N/A to $2.2 million in Q4 2010 from the same period last year, while for Dec 2010 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of $2.2 million for FY2010, which is N/A change from last year.
  • According to the latest figures from FY2010, Madrigal Pharmaceuticals' Non-Current Deffered Revenue is $2.2 million.
  • In the past 5 years, Madrigal Pharmaceuticals' Non-Current Deffered Revenue registered a high of $2.2 million during FY2010, and its lowest value of $2.2 million during FY2010.
  • Over the past 1 years, Madrigal Pharmaceuticals' median Non-Current Deffered Revenue value was $2.2 million (recorded in 2010), while the average stood at $2.2 million.